compound glp-1 fda New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our Hims & Hers stock falls

Lazarus has not

Atypical nevi are common, with a prevalence rate of about 5%

Proc Natl Acad Sci U S A 101:88412, PMID: 15187230 Into T, Inomata M, Nakashima M, Shibata K, Hcker H, Matsushita K (2008) Regulation of MyD88-dependent signaling events by S nitrosylation retards toll-like receptor signal transduction and initiation of acute-phase immune responses

The service covers six conditions: sinusitis, sore throats, infected insect bites, impetigo, shingles, and uncomplicated urinary tract infections (UTIs) in women

Those results outperformed the Chinese clinical trials of semaglutide (Ozempic) and tirzepatide (Zepbound), which helped 85% to 88% of participants lose 5% of more of their weight, researchers noted in their paper